Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1 to 112 of 112

TitleReference numberPublishedLast updated
Sedaconda ACD-S for sedation with volatile anaesthetics in intensive careHTG607
Glaucoma: diagnosis and managementNG81
Sodium zirconium cyclosilicate for treating hyperkalaemiaTA599
Rehabilitation after traumatic injuryNG211
Smart Peak Flow for monitoring asthmaMIB282
Cabotegravir with rilpivirine for treating HIV-1TA757
Solriamfetol for treating excessive daytime sleepiness caused by narcolepsyTA758
Prostate cancerQS91
Endo-SPONGE for treating low rectal anastomotic leakHTG605
Prostate cancer: diagnosis and managementNG131
Colorectal cancerNG151
Belimumab for treating active autoantibody-positive systemic lupus erythematosusTA752
Mogamulizumab for previously treated mycosis fungoides and Sézary syndromeTA754
Transanal total mesorectal excision for rectal cancerHTG603
Endobronchial nerve ablation for chronic obstructive pulmonary diseaseHTG604
ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infectionsHTG602
Pelvic floor dysfunction: prevention and non-surgical managementNG210
Urinary incontinence in womenQS77
Olaparib for maintenance treatment of BRCA mutation-positive metastatic pancreatic cancer after platinum-based chemotherapy (terminated appraisal)TA750
Dupilumab for treating severe asthma with type 2 inflammationTA751
FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndromeMIB281
Brain tumours (primary) and brain metastases in over 16sQS203
Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disordersTA748
Liraglutide for managing obesity in people aged 12 to 17 years (terminated appraisal)TA749
clonoSEQ for minimal residual disease assessment in multiple myeloma, acute lymphoblastic leukaemia and chronic lymphocytic leukaemiaMIB278
CerebAir for continuous EEG monitoring in intensive careMIB279
Paige Prostate for prostate cancerMIB280
Synergo for non-muscle-invasive bladder cancerHTG601
Fever in under 5s: assessment and initial managementNG143
Givosiran for treating acute hepatic porphyriaHST16
Chronic kidney disease: assessment and managementNG203
Percutaneous implantation of pulmonary artery pressure sensors for monitoring treatment of chronic heart failureHTG599
Coronary sinus narrowing device implantation for refractory anginaHTG600
Acute heart failure: diagnosis and managementCG187
SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoeaHTG598
Heart valve disease presenting in adults: investigation and managementNG208
Nintedanib for treating progressive fibrosing interstitial lung diseasesTA747
Nivolumab for adjuvant treatment of resected oesophageal or gastro-oesophageal junction cancerTA746
Upadacitinib for treating moderate rheumatoid arthritisTA744
NBTXR-3 for treating advanced soft tissue sarcoma (terminated appraisal)TA745
Inducing labourNG207
Inducing labourQS60
24/7 EEG SubQ for epilepsyMIB277
Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and managementNG206
Apalutamide with androgen deprivation therapy for treating high-risk hormone-relapsed non-metastatic prostate cancerTA740
Apalutamide with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancerTA741
Atezolizumab for untreated PD-L1-positive advanced urothelial cancer when cisplatin is unsuitableTA739
Genicular artery embolisation for pain from knee osteoarthritisHTG595
Laparoscopic renal denervation for loin pain haematuria syndromeHTG596
Percutaneous endovascular forearm arteriovenous fistula creation for haemodialysis accessHTG597
Looked-after children and young peopleNG205
Tofacitinib for treating juvenile idiopathic arthritisTA735
Nivolumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapyTA736
Berotralstat for preventing recurrent attacks of hereditary angioedemaTA738
Secukinumab for treating moderate to severe plaque psoriasis in children and young peopleTA734
Baloxavir marboxil for treating acute uncomplicated influenza (terminated appraisal)TA732
Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemiaTA733
DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiographyHTG594
Avapritinib for treating unresectable or metastatic gastrointestinal stromal tumours (terminated appraisal)TA730
Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal)TA731
Daratumumab with pomalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)TA726
Isatuximab with carfilzomib and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)TA727
Midostaurin for treating advanced systemic mastocytosisTA728
Sapropterin for treating hyperphenylalaninaemia in phenylketonuriaTA729
Lateral elbow resurfacing for arthritisHTG591
Transapical transcatheter mitral valve-in-valve implantation for a failed surgically implanted mitral valve bioprosthesisHTG592
Transapical transcatheter mitral valve-in-ring implantation after failed annuloplasty for mitral valve repairHTG593
Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapyTA725
OrganOx metra for liver transplantMIB275
Carnation Ambulatory Monitor for ambulatory detection of cardiac arrythmiasMIB276
Nivolumab with ipilimumab and chemotherapy for untreated metastatic non-small-cell lung cancerTA724
Workplace health: long-term sickness absence and capability to workQS202
End of life care for adultsQS13
Bimekizumab for treating moderate to severe plaque psoriasisTA723
Colli-Pee for first void urine collectionMIB273
PLASMA system with button electrode for electrovaporisation of the prostateMIB274
Babies, children and young people's experience of healthcareNG204
Pemigatinib for treating relapsed or refractory advanced cholangiocarcinoma with FGFR2 fusion or rearrangementTA722
Hysteroscopic mechanical tissue removal (hysteroscopic morcellation) for uterine fibroidsHTG590
Magnetic resonance therapy for knee osteoarthritisHTG588
Laparoscopic removal of uterine fibroids with power morcellationHTG589
Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16sNG202
Continuous positive airway pressure for the treatment of obstructive sleep apnoea/hypopnoea syndromeTA139
Antenatal careNG201
Venous thromboembolism in adultsQS201
Melatonin for treating sleep disorders in adults who are blindES38
Chlormethine gel for treating mycosis fungoides-type cutaneous T-cell lymphomaTA720
Antimicrobial prescribing: delafloxacin for community-acquired pneumoniaES37
MMprofiler for prognostic risk classification in multiple myelomaMIB270
Patient Status Engine for wireless monitoring of vital signsMIB271
Lung texture analysis for measuring interstitial lung diseasesMIB272
Bronchiolitis in children: diagnosis and managementNG9
Immunoscore for predicting risk of colon cancer relapseMIB269
Nivolumab with ipilimumab for previously treated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiencyTA716
Inducing and maintaining normothermia using temperature modulation devices to improve outcomes after stroke or subarachnoid haemorrhageHTG587
Clostridioides difficile infection: antimicrobial prescribingNG199
Duvelisib for treating relapsed follicular lymphoma after 2 or more systemic therapies (terminated appraisal)TA717
ENDURALIFE powered CRT-D devices for treating heart failureHTG433
Ixekizumab for treating active ankylosing spondylitis and non-radiographic axial spondyloarthritisTA718
Secukinumab for treating active non-radiographic axial spondyloarthritisTA719
Adalimumab, etanercept, infliximab and abatacept for treating moderate rheumatoid arthritis after conventional DMARDs have failedTA715
Dasatinib for treating Philadelphia-chromosome-positive acute lymphoblastic leukaemia (terminated appraisal)TA714
HealthVCF for detecting vertebral compression fractures on CT scansMIB267
trublood-prostate for triaging and diagnosing people with prostate cancer symptomsMIB268
Enzalutamide for treating hormone-sensitive metastatic prostate cancerTA712
Nivolumab for advanced non-squamous non-small-cell lung cancer after chemotherapyTA713
AI technologies for detecting diabetic retinopathyMIB265
Acumen IQ sensor for predicting hypotension riskMIB266
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillationTA249
Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillationTA355
Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillationTA256
Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillationTA275

Results per page

  1. 10
  2. 25
  3. 50
  4. All